SE8802790D0 - Tripeptider med immunostimulerande och metastasforhindrande verkan - Google Patents

Tripeptider med immunostimulerande och metastasforhindrande verkan

Info

Publication number
SE8802790D0
SE8802790D0 SE8802790A SE8802790A SE8802790D0 SE 8802790 D0 SE8802790 D0 SE 8802790D0 SE 8802790 A SE8802790 A SE 8802790A SE 8802790 A SE8802790 A SE 8802790A SE 8802790 D0 SE8802790 D0 SE 8802790D0
Authority
SE
Sweden
Prior art keywords
tripeptides
metastas
immunostimulating
prevention effects
asp
Prior art date
Application number
SE8802790A
Other languages
English (en)
Other versions
SE8802790L (sv
Inventor
B Brunetti
M Prada
Original Assignee
Ellem Ind Farmaceutica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellem Ind Farmaceutica filed Critical Ellem Ind Farmaceutica
Publication of SE8802790D0 publication Critical patent/SE8802790D0/sv
Publication of SE8802790L publication Critical patent/SE8802790L/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • C07K5/0817Tripeptides with the first amino acid being basic the first amino acid being Arg
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8802790A 1987-08-04 1988-08-02 Tripeptider med immunostimulerande och metastasfoerhindrande verkan SE8802790L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21575/87A IT1222437B (it) 1987-08-04 1987-08-04 Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione

Publications (2)

Publication Number Publication Date
SE8802790D0 true SE8802790D0 (sv) 1988-08-02
SE8802790L SE8802790L (sv) 1989-02-05

Family

ID=11183828

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802790A SE8802790L (sv) 1987-08-04 1988-08-02 Tripeptider med immunostimulerande och metastasfoerhindrande verkan

Country Status (13)

Country Link
US (1) US4929601A (sv)
JP (1) JPS6463593A (sv)
AT (1) ATA195788A (sv)
BE (1) BE1003227A3 (sv)
CH (1) CH678059A5 (sv)
DE (1) DE3826595C2 (sv)
FR (1) FR2621317B1 (sv)
GB (1) GB2207922B (sv)
GR (1) GR1000339B (sv)
IE (1) IE60870B1 (sv)
IT (1) IT1222437B (sv)
NL (1) NL8801932A (sv)
SE (1) SE8802790L (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156490A (en) * 1976-05-25 1979-05-29 Prot S.R.L. Method of hermetically sealing soft-drink bottles and like containers
DE3855458T2 (de) * 1987-12-10 1996-12-05 Jolla Cancer Res Found Verfahren zur herstellung von conformationnell stabilisierten zelladhäsionspeptiden
US5827821A (en) * 1987-12-10 1998-10-27 The Burnham Institute Conformationally stabilized cell adhesion peptides
CA1324954C (en) * 1988-03-10 1993-12-07 Erkki I. Ruoslahti Inhibition of cell migration with synthetic peptides
US5236903A (en) * 1988-06-24 1993-08-17 Ichiro Azuma Polypeptide comprising repeated cell-adhesive core sequences
JP2625156B2 (ja) * 1988-06-24 1997-07-02 市郎 東 細胞接着活性コア配列の繰り返し構造からなるポリペプチド
IT1226552B (it) * 1988-07-29 1991-01-24 Ellem Ind Farmaceutica Peptidi immunostimolanti.
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5770564A (en) * 1989-06-16 1998-06-23 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5795867A (en) * 1989-06-16 1998-08-18 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5648330A (en) * 1990-04-06 1997-07-15 La Jolla Cancer Research Foundation Method and composition for treating vascular graft occlusion
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
ES2104702T3 (es) * 1990-04-06 1997-10-16 Jolla Cancer Res Found Metodo y composicion para el tratamiento de la trombosis.
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
AU9131091A (en) * 1990-11-07 1992-06-11 Scripps Research Institute, The Peptides that inhibit platelet binding of adhesion molecules
EP0578728B1 (en) * 1991-04-05 1998-07-01 Genentech, Inc. PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIIIa
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
KR101116528B1 (ko) 2003-05-08 2012-02-28 디에스엠 아이피 어셋츠 비.브이. 피부구조를 향상시키는 트리펩타이드 및 그 유도체의 미용용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508710A (en) * 1978-07-31 1985-04-02 Proter S.P.A. In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound
US4743590A (en) * 1978-07-31 1988-05-10 Debarbieri Augusto In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound
HU185263B (en) * 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
FR2569111B1 (fr) * 1984-08-16 1987-04-17 Rhone Poulenc Sante Nouveaux medicaments contenant des tripeptides

Also Published As

Publication number Publication date
CH678059A5 (sv) 1991-07-31
GB8818447D0 (en) 1988-09-07
JPS6463593A (en) 1989-03-09
GB2207922A (en) 1989-02-15
DE3826595A1 (de) 1989-02-16
DE3826595C2 (de) 1994-02-17
NL8801932A (nl) 1989-03-01
GR1000339B (el) 1992-06-25
FR2621317B1 (fr) 1994-06-17
IE882366L (en) 1989-02-04
FR2621317A1 (fr) 1989-04-07
ATA195788A (de) 1996-05-15
BE1003227A3 (fr) 1992-02-04
US4929601A (en) 1990-05-29
GR880100509A (en) 1989-05-25
IT8721575A0 (it) 1987-08-04
SE8802790L (sv) 1989-02-05
IE60870B1 (en) 1994-08-24
IT1222437B (it) 1990-09-05
GB2207922B (en) 1991-02-20

Similar Documents

Publication Publication Date Title
SE8802790L (sv) Tripeptider med immunostimulerande och metastasfoerhindrande verkan
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO169070C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterosyklisk-n-(4-piperidyl)-amider
SE8900039D0 (sv) Isoquinoline derivatives their preparation and their use
ATE123944T1 (de) Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen.
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO870049L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
NO881835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
MY113427A (en) Anti-neurodegeneratively active 10-aminoaliphatyl- dibenz [b,f] oxepines
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
AP9801235A0 (en) Erythromycin derivatives.
KR870010080A (ko) 면역촉진 활성을 갖는 트리펩티드
FI884911A (fi) Laekemedel, i dessa saosom aktiva aemnen befintliga fosforin innehaollande 2-isoxazoliner och isoxazoler samt foerfarande foer framstaellning av dessa heterocykliska foereningar.
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
DE69429447T2 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
DE69630876D1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
DE59107405D1 (de) Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen
ATE210985T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
PT760375E (pt) Derivado de indolopiprolocarbazole anti-tumoral
ES2013877A6 (es) Nuevo procedimiento para producir derivados de imidazopiridina.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8802790-9

Format of ref document f/p: F